Dr. Adam Wolfberg, Virta Health, on Reversing Type 2 Diabetes and Rethinking GLP-1s

https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/86/e2/57/86e257d0-1d34-9e08-b7c9-2f579bcd76cb/mza_14705837628810478855.jpg/600x600bb.jpg

The Pulse by Wharton Digital Health

125 episodes

1 week ago

Capturing the pulse of healthcare innovation spanning leaders across the healthcare ecosystem.

All content for The Pulse by Wharton Digital Health is the property of The Pulse by Wharton Digital Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Capturing the pulse of healthcare innovation spanning leaders across the healthcare ecosystem.

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/1197338/1197338-1743988852121-b88c529a474f6.jpg

Dr. Adam Wolfberg, Virta Health, on Reversing Type 2 Diabetes and Rethinking GLP-1s

The Pulse by Wharton Digital Health

45 minutes 4 seconds

7 months ago

Dr. Adam Wolfberg, Virta Health, on Reversing Type 2 Diabetes and Rethinking GLP-1s

In this episode of The Pulse, I sat down with Dr. Adam Wolfberg, Chief Medical Officer of Virta Health, a company pioneering a new approach to tackling metabolic disease.

Virta Health has a mission to reverse type 2 diabetes and obesity through nutrition-first treatment and tech-enabled care. We discussed Adam’s unconventional journey from news reporter to startup exec, Virta’s science-backed outcomes, and why GLP-1s aren’t the only answer to America’s weight crisis.